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Purpose: While oxidative stress is thought to be an important cause of male infertility, primarily 
due to DNA and cell membrane damage, little is known about the genetic causes underlying 
suboptimal function of the seminal enzymatic antioxidant system. The aim of this study was to 
investigate the relationship of 4 potentially functional polymorphisms associated to oxidative 
stress pathway genes (superoxide dismutase - SOD2.lle58Thr and SOD2.rs4880, Catalase – 
CAT C-262T, glutathione peroxidase 1 - GPX1 Pro200Leu) and 2 null variants of the 
gluthathione S transferase (GSTT and GSTM) genes and infertility risk. 
 
Methods: A case control study was conducted on 313 infertile patients and 80 fertile donors. 
Each ejaculate was subjected to a seminal analysis which included the classical parameters 
seminal volume, sperm concentration, sperm motility and sperm morphology, as well as sperm 
DNA fragmentation (patients only). Polymerase chain reaction-restriction fragment length 
polymorphism (PCR_RFLP) and PCR multiplex methods were carried out for genotyping. 
  
Results: Statistically significant differences were found between fertile donors and infertile 
patients for SNP CAT C-262T; the CC genotype was related with a 2 fold increased risk of 
infertility (OR = 2.262; 95%CI = 1.369 - 3.733; P = 0.001) while the CT genotype was 
associated with a protective effect (OR = 0.401; 95%CI = 0.241 - 0.667; P = 0.001). 
Surprisingly, the SOD2 Ile58Thr SNP was not represented in the sample population, so it’s 
frequency in the current population frequenting fertility clinics in Madrid may be very low.  
 
Conclusions: Our results suggest that the CAT SNP C-262T is potentially associated with an 






Reactive oxygen species (ROS) are free radicals having at least one unpaired electron 
and include molecules such the hydroxyl ion [OH], superoxide ion [O2], peroxyl radical [RO2] or 
hydrogen peroxide [H2O2]. ROS originate from cellular reactions as by-products of the 
metabolism of oxygen and are normally neutralized by the homeostatic antioxidant systems. 
The ROS present in seminal plasma can originate from both endogenous or exogenous 
sources; endogenous sources may be derived from a high incidence of leukocytes in the 
seminal plasma and an overabundance of immature spermatozoa (sperm cells with residual 
cytoplasm) in the ejaculate of patients with varicocele [1-3]. ROS in seminal plasma may also 
originate from exogenous sources such as exposure to ionising radiation, cytotoxins or poor 
lifestyle choice, including cigarette smoking or excessive alcohol consumption [4].  
 
While the presence of ROS in seminal plasma is normally balanced by homeostatic 
antioxidant systems that facilitate an appropriate level of ROS required for normal physiological 
processes such as sperm capacitation, hyperactivation, acrosome reaction and sperm-oocyte 
fusion, in some circumstances, unbalanced REDOX potential (a measure of oxidative stress 
defined as all known and unknown contributors of oxidative stress and not limited to a specific 
constituent as is the case in ROS or TAC assays), may arise due to an elevated production of 
ROS that is beyond the capacity of the animal’s inherent antioxidant systems to cope with. 
Under such circumstances, high levels of ROS in the seminal plasma have the potential to not 
only cause sperm DNA damage, but also lipid peroxidation, sperm motility and membrane 
fluidity reduction and apoptosis [5-6].  
 
The enzymatic antioxidant systems in seminal plasma are a group of enzymes that 
include, manganese superoxide dismutase (SOD2), catalase (CAT), glutathione peroxidase 1 
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(GXP1) and gluthathione S transferase (GST) [7]. SOD2 is an enzyme that catalyses the 
detoxification of superoxide radicals in the mitochondrion [8-10]. Catalase has the capacity to 
detoxify H2O2 by converting it into H2O and O2 [11,12]. The GXP1 enzyme is related to the final 
electron transporter and neutralizes peroxide radicals into H2O [13], whereas GST conjugates 
toxic electrophiles and other intermediates, with glutathione negating their toxicity [14].  
 
Although these enzymes appear to be conserved phylogenetically, species and 
individual specific polymorphisms may still produce changes in regard to their respective 
activities and, therefore, may be useful in understanding the underlying origins of idiopathic 
infertility. Hence, the aim of the current study was to elucidate and establish a genetic basis to 
investigate the relationship of enzymes associated with antioxidant system failure, conventional 
parameters of the WHO accredited sperm analysis and male infertility. To examine this 
hypothesis, we compared the incidence of 6 potentially functional polymorphisms thought to be 
linked to oxidative stress pathway genes (SOD2, CAT, GXP1, GSTM and GSTT) in infertile 
patients and donor controls with proven fertility attending a Spanish infertility clinic.  
 
Materials and methods 
 
Subjects and sample collection 
 
The study was approved by the Bioethics Committee of the Universidad Autónoma de 
Madrid (CEI 60-1058). Semen samples from a total of 393 subjects (patients and donors) 
attending a Spanish Fertility Clinic were analysed consisting of 313 infertile patients undergoing 
infertility IVF/ICSI treatment and 80 donors with proven fertility who had already fathered at least 
one child. The patient cohort consisted of individuals that showed no evidence of any other 
fertility related diseases, such us prostate cancer, cryptorchidism, varicocele, diabetes, seminal 
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infections or karyotype abnormalities. Each male donated 1 mL (patient cohort) or 0.5 mL 
(donor cohort) of semen that was obtained by masturbation after at least 4 days of abstinence; 





Each ejaculate was subjected to a classical seminal analysis approximately 30 min after 
liquefaction based on the recommendations and semen evaluation protocols and standards of 
the World Health Organization (2010) [15]; parameters analysed included seminal volume, 
sperm concentration, sperm motility and sperm morphology. 
 
Sperm DNA fragmentation 
 
Sperm DNA fragmentation (SDF) was assessed for all the samples in the patient cohort  
using the Sperm Chromatin Dispersion Assay (SCD; Halosperm Kit, Halotech DNA, Madrid, 
Spain) according to the manufacturer’s instructions. Processed slides were stained with SYBR-
Green (SYBR-Green 10000x, Cat No S7563, Thermo Fisher Scientific, Brawnschweig, 
Germany), mounted with Vectashield (Vectashield Mounting Medium, Cat No H-1000, Vector 
Laboratories, Burlingame,USA) and observed with epifluorescence microscopy (Leica DMRB, 




DNA extraction was performed using the phenol-chloroform method with proteinase-K 
treatment. Briefly, 500 µL of liquefied semen was centrifuged at 1800 rpm and the pellet re-
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suspended in 100 µL of seminal plasma. This sample was then incubated overnight in a solution 
consisting of 8 µL 10 mg mL-1 proteinase K (Proteinase K Recombinant PCR Grade, Cat No 03 
115 887 001, Roche, Mannheim, Germany), 8µL of 1M DTT and 100µL extraction buffer (20mM 
Tris-Cl, 20mM EDTA, 200mM NaCl, 4% SDS). Thereafter, 216 µL of phenol 
(Phenol/Chloroform/Isoamyl alcohol 25:24:1, Cat No 327115000, Acros Organics, New Jersey, 
USA) was added to the semen sample and the mixture agitated on a mechanical shaker for 2 
min after which it was centrifuged at 8000 rpm for 10 min. The upper aqueous phase was then 
recovered and the same operation performed with 200 µL of chloroform:isoamil 24:1 
(Chloroform reagent grade - Cat No CL02031000, Scharlab, Spain; Isoamylalkohol >98% - Cat 
No 818969, Merck, Munich, Germany). The upper aqueous phase was then recovered once 
more to which 250 µL of cold (-20 ºC) 100% ethanol was also added. This solution was gently 
shaken until the DNA precipitated and the sample left to stand overnight at -20 ºC. The DNA 
was then washed with cold (-20 ºC) 70% ethanol and air dried. To eliminate contaminating RNA, 
the pellet was re-suspended in 50 µL of TRIS-EDTA buffer with 0.5 µL of 1mg mL-1 RNAse 
(RNase DNase free, Cat No 11 119 915 001, Roche, Mannheim, Germany) and incubated for 2 
h at 37 ºC. Finally, the concentration of the extracted DNA was determined using a NanoDrop 
ND-1000 (Thermo Scientific, Brawnschweig, Germany) before diluting to a concentration of 50 




SOD2 Ile58Thr, SOD2 Val16Ala (rs4880), CAT C-262T (rs1001179) and GXP1 
Pro200Leu (rs1050450) genotypes were determined using the polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) method. PCR products were then 
digested with the restriction enzymes EcoRV, HaeIII, SmaI and HaeIII, respectively (FastDigest 
Restriction Enzymes, Cat Nos FD0303, FD 0154, FD0664, Thermo Scientific, Brawnschweig, 
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Germany). The respective primer sequences and the restriction enzymes are shown in Table 1. 
GSTM1-GSTT1 genotyping was performed using a PCR multiplex protocol [16]. Briefly, 3 sets 
of primers where used in an unique PCR mix: forward 5’-GAACTCCCTGAAAAGCTAAAGC-3’ 
and reverse 5’-GTTGGGCTCAAATATACGGTTT-3’ for GSTM1, forward 5’-
TTCCTTACTGGTCCTCACATCTC-3’ and reverse 5’-TCACCGGATCATGGCCAGCA-3’ for 
GSTT1 and forward 5’-GCCCTCTGCTAACAAGTCCTAC-3’ and reverse 5’-
GCCCTAAAAAGAAAATCGCCAATC-3’ for albumin, as an internal control. PCR product sizes 




Statistical analysis was performed using the SPSS 22 software for Windows (SPSS Inc., 
Chicago. USA). Associations between categorical variables (genotype frequencies and odds 
ratios) were assessed by a chi-square test. Continuous variables (seminal parameters) were 
compared between groups using non-parametric tests (Mann-Whitney U-test - comparison 
between 2 groups and Kruskal-Wallis - comparison between more than 2 groups). Results were 
expressed as odds ratio (OR) with 95% confidence intervals (CI). A P value of <0.05 was 




The demographic and clinical profiles of the patient and donor cohorts analysed in this 
study are shown in Table 2; as expected, significant differences between both cohorts were 





Genotype frequencies of each of the polymorphisms in the patient and donor cohort, 
along with the statistical level of significance are show in Table 3. Polymorphisms were 
observed for all SNPs but in the case of the SOD2 Ile58Thr polymorphism, only dominant 
homozygotes (Thr/Thr) were found. A significant difference in genotype frequency between the 
cohorts was only observed for the CAT -262C>T SNP. The CC genotype was less frequent in 
the donor cohort (50%) compared to that of the patient group (69%), while the frequency of the 
CT genotype was almost double in the donor cohort (47%) compared to that found in the patient 
cohort (26%) (P = 0.002). 
 
The odds ratio (OR) of being infertile for each genotype was calculated against the other 
two genotypic options. A significant OR was only noted in catalase CC and CT genotypes 
(Figure 1); in fact, the CC genotype was associated with a 2 fold increased risk of infertility (OR 
= 2.262; 95% CI = 1.369 - 3.733; P = 0.001), while the CT genotype was associated with a 
protective effect (OR = 0.401; 95% CI = 0.241 - 0.667; P = 0.001). 
 
Median differences in classical seminal parameters (seminal volume, sperm 
concentration, % sperm motility, % sperm morphology and % SDF) were compared between 
patients and donors for each of the genotypes (Table 4). The results of the analysis revealed 
significant differences for only the catalase SNP with respect to motility (P = 0.047) and 
morphology (P = 0.024). Pairwise comparisons for these parameters also revealed significant 
differences for morphology between the CC and CT genotypes (H = -32.187, adjusted P = 
0.029, r = -0.130). Moreover, analysis of the median values for sperm concentration between 








This study explored the association of 6 polymorphisms of antioxidant enzymes 
(SOD2.lle58Thr, SOD2.rs4880, CAT C-262T, GPX1 Pro200Leu, GSTT and GSTM) with 
observed infertility in patients from a Spanish fertility clinic; a statistically significant association 
was observed between the SNP for CAT C-262T and infertility. The CT genotype was 
associated with a protective or beneficial effect with respect to fertility. 
 
For the purposes of this study we have assumed that donors and patients attending the 
clinic were representative of the current Spanish cosmopolitan population as the clinic is located 
in Madrid (Spain); we therefore compared the genotype frequencies of the Madrid population 
with that obtained for the same polymorphisms in other European populations (Table 5) [13, 17]. 
We observed that for SNP GPX Pro200Leu and for the variants of the GST enzymes our 
frequencies were within or close to within the frequency limits obtained for the same 
polymorphisms of other European populations. For the SNP SOD rs4880 the only differing 
frequency was for the heterozygote genotype (0.56 vs 0.28 to 0.47). In contrast, the SNP CAT 
C-262T was the one of the largest differences for all genotype options, while for SNP SOD2 
Ile58Thr, we could only find the dominant homozygote genotype in the current population. 
 
The catalase enzyme (CAT), coded in chromosome 11p3, is the main enzyme in the 
detoxification of H2O2 to H2O. H2O2 plays an important role in male infertility as it causes lipid 
peroxidation, which reduces the fluidity of the membrane, thus causing a reduction in motility 
and poor oocyte-sperm membrane fusion [18, 19]. H2O2 in seminal plasma can appear directly 
as a consequence of the activity of leukocytes or indirectly as a product of the detoxification of 
ROS by superoxide dismutase. It has been shown that seminal plasma of infertile patients has a 
higher H2O2 concentration and a lower catalase activity than that of healthy controls [20]. 
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Recent studies have also demonstrated that an external supplementation with catalase when 
cryopreserving semen improves post-thaw sperm motility and sperm viability [21].  
 
In the current study we found significant differences in the genotype frequencies for SNP 
CAT C-262T between patients and fertile donors. Specifically, we observed an increased 
frequency (almost double) of the CT genotype in donors when compared with patients. Thus, 
we hypothesise that the T allele may be a variant of the enzyme with a higher transcriptional 
rate and be beneficial in heterozygosity. This observation is concordant with the studies of 
Sabouhi et al. [12] and Foresberg et al. [22], both of whom observed the T allele to be related to 
higher catalase levels. In contrast, Tefik et al. [11] and Ahn et al. [23] showed a lower enzyme 
activity for the CT and TT genotypes of the CAT C-262T polymorphism; it is possible that these 
differences may be a consequence of the particular characteristics of the populations included 
in each study. According to Suzan et al. [13] the CAT C-262T polymorphism shows important 
differences in the genotype frequencies between populations. Moreover, when we compared 
the values of the main parameters of the traditional sperm analysis between genotypes we 
observed that the highest quality values for all parameters appeared in the genotypes 
containing the T allele. Significant differences between genotypes were also obtained for motility 
and morphology, although pairwise comparisons only revealed significant differences for 
morphology between the CT and CC genotypes, with CT genotype being associated with better 
semen quality; close to significant differences were also apparent for the sperm concentration 
parameter. Moreover, for sperm DNA fragmentation, the highest sperm quality was also found 
associated with the CT genotype. Finally, it was noted that the occurrence of infertility was 2.26 
times more likely to be associated with the CC genotype, than for the other 2 genotypes, while 
the CT genotype showed a protective effect; these observations support the hypothesis that the 




Manganese superoxide dismutase 2 (SOD2) is a mitochondrial antioxidant enzyme 
coded in chromosome 6q25. It catalyses the detoxification of superoxide radicals in the 
mitochondrion producing H2O2 and O2 as by-products. In the SOD2 rs4880 polymorphism there 
is a change of Ala to Val in position -9 of the N-terminal mitochondrial targeting sequence which 
leads to a variant of the enzyme that is less efficiently transported to the mitochondrion [24]. The 
results of our study were not consistent with this hypothesis as we observed a slightly higher 
representation of the Val allele in fertile donors than in patients. However, our results are 
concordant with the observations of Yan et al. [10] that found a higher presence of the Val allele 
in fertile males; they suggested that the higher efficient Ala allele should produce higher levels 
of H2O2 which may be detrimental for sperm quality. Moreover, we noted that Ala/Val and 
Val/Val genotypes were associated with higher quality seminal parameters, although the 
differences between these genotypes were low; in addition, the Ala/Ala genotype showed a 1.6 
times higher odds ratio of being infertile than the other two genotypes.   
 
The Sod2 Ile58Thr polymorphism affects the stability of the protein [11]. In our study we 
could not find a representation of that polymorphism in our population as we only found the 
Ile/Ile genotype both in patients and in donors; this observation would suggest that the Ile/Ile 
genotype is over-represented in our studied population. 
 
The glutathione peroxidase 1 enzyme (GPX1), coded in chromosome 3p21, is a 
selenium dependent peroxidase and is ubiquitously expressed in humans. It works as the final 
electron transporter that neutralizes peroxide radicals to water and oxygen [25]. In the 
Pro200Leu polymorphism, there is a substitution of Pro to Leu at codon 200 located in the c-
terminal region of the protein. Najafi et al. [26] in a computer predictor study concluded that this 
polymorphism is located on the protein surface in a non-functional region and that the 
substitution does not affect protein stability or structure. However, Hu et al. [27] concluded that 
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the Leu allele is less effective than the Pro allele when neutralizing peroxide radicals; in contrast 
with this observation, our results showed a higher presence of the Leu allele in fertile donors 
than in patients and better values for almost all the parameters in the traditional sperm analysis 
in the Leu/Leu genotype group (the only parameter differing was the volume). Curiously, we 
also found significant differences between genotypes for the parameter volume, both in the 
patient population and in the global analysis. The odds ratio analysis for infertility showed that 
the ratio of being infertile was almost similar for the Pro/Leu and Leu/Leu genotypes and was 
1.27 times higher for the Pro/Pro genotype than for the other two.  
 
Glutathione S transferase (GST) comprises a family of enzymes which conjugate toxic 
intermediates with glutathione inactivating them and facilitating their excretion. GSTM 
(chromosome 1p13.3) and GSTT (chromosome 22q11.2) are two human GST isozymes which 
can present a null allele as a result of a deletion. Several studies have been carried out recently 
to try and clarify the relationship between the null variants and male infertility but this 
relationship is still controversial. For the GSTM null genotype, some studies have concluded 
that it is associated with a higher risk of male infertility [28, 29] but others show no relationship 
at all [14]. Similarly, although several studies have shown a relationship between the GSTT null 
genotype and male infertility [30] there are others that reveal no relationship or even a beneficial 
effect of the null genotype with respect to male infertility [14]. Moreover, some studies point out 
that the effects of both null genotypes may also be related to exposure to air pollution [31]. In 
our study, we observed almost similar frequencies and an odds ratio of infertility for both 
patients and donors with respect GSTT, whereas the GSTM null genotype showed a slightly 
higher frequency in patients than in donors and an odds ratio indicating that the occurrence of 
infertility was 1.25 times more likely than for the wild variant. Consequently, our findings are 




We are aware that our study has both strengths and weaknesses. The first strength is 
the relatively high number of individuals included in the study; second, all subjects included in 
the donors’ cohort had proven fertility as they had already fathered at least one child. With 
respect to the study's weaknesses, althoughwe knowthat there is a difference in themean age of 
the two cohorts included in the study, all males included in the study were young men within the 
well-recognized fertility window and we are confident that this difference is not confounding our 
results as age does not influence genotypic frequencies. In addition, although seminal 
parameters are influenced by patient exposure factors such as BMI, smoking, and diet, these 
aspects are difficult or virtually impossible to fully define in the individual patients and thus we 
have not considered them in our study. 
In conclusion, we found statistically significant differences for SNP CAT C-262T between 
fertile donors and infertile patients, with the CT genotype showing a potentially protective role. 
However, we also found interesting associations for the other polymorphisms we examined that 
could help us to understand the roles of the antioxidant pathways in ROS related male infertility. 
According to our observations, we predict that males with the Val allele in SOD gene, the Leu 
allele in GPX gene and GSTs with wild variants should have a better response to increased 
ROS. We are confident that more research as to the relationship between gene polymorphisms 
associated with seminal plasma antioxidant capacity will lead to a better understanding of male 
factor infertility and could therefore be applied to improve both patient diagnosis and donor 
selection with genetic background testing. 
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Table 1. Primers and restriction enzymes used in the PCR-RFLP study. 
 














































Table 2. Demographic and clinical profile of the participant subjects (Mean ± Standard 
deviation). P-value calculated with the Mann-Whitney U-test. 
 
Patients Donors P-value 
Age (year) 37.81 ± 5.05 24.76 ± 4.96 <0.001 
Volume (mL) 3.33 ± 1.36 3.19 ± 1.19 0.431 
Sperm Concentration (X 106 mL-1) 26.93 ± 18.41 53.82 ± 18.92 <0.001 
Motility (%) 38.93 ± 12.22 54.55 ± 6.36 <0.001 
Morphology (%) 3.41 ± 1.87 6.41 ± 1.71 <0.001 















Genotype n (obs) Genotype 
frequency 
n (obs) Genotype 
frequency 
P-value 
Sod2 Ile58Thr  
   
 
Thr/Thr 313 1.00 80 1.00  
Ile/Thr 0 0.00 0 0.00 0 
Ile/Ile 0 0.00 0 0.00  
Sod2 rs4880 
    
 
Ala/Ala 69 0.22 12 0.15  
Ala/Val 150 0.48 45 0.56 0.329 
Val/Val 94 0.30 23 0.29  
CAT -262 C>T 
    
 
CC 215 0.69 40 0.50  
CT 82 0.26 37 0.47 0.002 
TT 16 0.05 3 0.03  
GPX1 Pro200Leu 
    
 
Pro/Pro 139 0.44 31 0.39  
Pro/Leu 138 0.44 38 0.47 0.669 
Leu/Leu 16 0.12 11 0.14  
GSTT 
   
  
Present 246 0.79 63 0.78  
Absent 67 0.21 17 0.22 0.975 
GSTM 
   
  
Present 151 0.48 43 0.53  











Figure 1: Forest plot of infertility risk for each genotype. Horizontal lines represent 95% CI. Each 
square represents the OR point. The vertical line is at the null value (OR=1). P-value calculated 











Table 4. Extended analysis of traditional seminal parameters for genotypes comparing patients 
versus donors. The data shown are the mean for volume (mL), concentration (106 mL-1), motility 
(%), morphology (%), DNA fragmentation (%). P-value1 = comparison between genotypes from 
patients and donors, P-value2 = comparison between genotypes for all 393 samples. Statistical 
analysis - the Kruskal-Wallis test was used to compare for volume, sperm % motility, 
%morphology and % DNA fragmentation for the 3 genotypes, whereas, the Mann-Whitney U-









 Ala/Ala Ala/Val Val/Val   
Volume Patients 3.25 3.43 3.21 0.749 0.781 
Donors 3.08 3.27 3.08 0.722 
Concentration  Patients 26.19 26.83 27.47 0.983 0.736 
Donors 51.50 54.56 53.60 0.984 
Motility  Patients 37.04 39.85 38.54 0.354 0.108 
Donors 55.83 54.77 53.47 0.567 
Morphology  Patients 3.34 3.43 3.39 0.955 0.526 
Donors 6.41 6.59 6.04 0.768 
DNA 
fragmentation  
Patients 21.06 19.31 19.32 0.634 0.634 
Donors 
   
 
CAT -262 C>T 
 
 CC CT TT   
Volume Patients 3.37 3.16 3.53 0.504 0.820 
Donors 3.07 3.36 2.60 0.487 
Concentration Patients 26.26 27.51 33.02 0.419 0.051 
Donors 52.93 53.94 64.00 0.294 
Motility Patients 38.48 38.72 45.93 0.080 0.047 
Donors 55.25 54.18 50.00 0.171 
Morphology Patients 3.31 3.54 4.12 0.159 0.024 
Donors 6.48 6.48 5.00 0.088 
DNA 
fragmentation 
Patients 19.84 18.66 22.88 0.849 0.849 
Donors 





 Pro/Pro Pro/Leu Leu/Leu   
Volume Patients 3.31 3.49 2.79 0.018 0.044 
Donors 3.20 3.20 3.11 0.983 
Concentration Patients 27.92 25.37 29.05 0.780 0.701 
Donors 53.19 54.05 54.81 0.789 
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Motility Patients 38.64 38.88 39.44 0.830 0.783 
Donors 55.64 54.05 53.18 0.642 
Morphology Patients 3.41 3.31 3.75 0.597 0.618 
Donors 6.25 6.59 6.18 0.866 
DNA 
fragmentation 
Patients 20.88 19.06 17.64 0.509 0.509 
Donors 




 Wild (+) 
 
Nul (-)   
Volume Patients 3.33  3.33 0.651 0.889 
Donors 3.25  2.95 0.508 
Concentration Patients 27.50  24.85 0.569 0.604 
Donors 53.46  58.76 0.620 
Motility Patients 39.00  38.65 0.921 0.859 
Donors 54.91  54.91 0.340 
Morphology Patients 3.42  3.35 0.855 0.986 
Donors 6.21  6.21 0.460 
DNA 
fragmentation 
Patients 19.65  19.82 0.923 0.923 
Donors     
GSTM    Wild (+)  Null (-)   
Volume Patients 3.32  3.34 0.464 0.719 
Donors 3.30  3.05 0.460 
Concentration Patients 27.25  26.64 0.704 0.460 
Donors 53.14  54.59 0.961 
Motility Patients 39.93  38.00 0.365 0.266 
Donors 53.81  55.40 0.152 
Morphology Patients 3.46  3.36 0.455 0.256 
Donors 6.54  6.24 0.556 
DNA 
fragmentation 
Patients 19.33  20.03 0.819 0.819 











Table 5: Frequencies obtained for the polymorphisms in other studies with European population. 
Adapted from Suzen et al. [13] and Xiong et al. [17] 
 Dominant homozygote Heterozygote Recessive 
homozygote 
SOD2 Ile58Thr 0.65 0.32 0.02 
SOD2 rs4880 0.06-0.054 0.28-0.47 0.08-0.52 
CAT C-262T 0.57-0.63 0.30-0.37 0.03-0.05 
GPX Pro200Leu 0.41-0.59 0.35-0.45 0.06-0.15 
GSTT   0.13-0.26 
GSTM   0.42-0.60 
 
